Foxo technologies™ collaborates with datarobot to pave the way for ai-driven epigenetic biomarker research in human longevity

Minneapolis--(business wire)--foxo technologies inc. (nyseam: foxo), a leader in the field of commercializing epigenetic biomarker technology, has advanced in its mission to utilize the power of epigenetics and artificial intelligence to generate data-driven insights that promote optimal health and longevity. in collaboration with datarobot, the leader in value-driven ai, foxo has successfully harnessed the powers of predictive ai and high-throughput automation to estimate factors associated wi.
FOXO Ratings Summary
FOXO Quant Ranking